CANN focuses on extraction and the creation of derivative products for recreational and medical consumers.
Heritage Cannabis Holdings (CANN.C) signed into a supply agreement with IntelGenx (IGX.V) to manufacture and supply filmstrip products containing 10 mg of CBD for the
No cannabis companies splits investors squarely down the middle like Heritage Cannabis (CANN.C). Despite ongoing good news and deals with larger players, a sizable section
Heritage Cannabis Holdings (CANN.C) got their first order from the Alberta Gaming, Liquor and Cannabis Commission (AGLC) to start selling products in the province, according
Heritage Cannabis Holdings (CANN.C) announced the execution of a binding letter of intent with pharmaceutical film developer, IntelGenx (IGX.V), to supply CBD filmstrips for the
Heritage Cannabis Holdings (CANN.C) signature tincture brands, Pura Vida and Purefarma, will be on shelves in British Columbia through the province’s Liquor Distribution Branch (LDB)
Unpopular opinion time. Aside from the inconvenience of actually getting sick, the fallout from the COVID-19 pandemic has been vastly worse than the disease itself.
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
A widening distribution net with award winning products and it shouldn’t come as much of a surprise that Heritage Cannabis (CANN.C) has had an excellent
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
Heritage is positioning itself to radically expand its sales territory.
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”.
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019.
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote Chris Parry on January 31, 2020.
Heritage Cannabis Holdings (CANN.C) subsidiary Purefarma added another piece of their portfolio expansion today, adding three vape cartridges to their existing catalog of intended product
Heritage Cannabis Holdings (CANN.C) intends to launch their Pura Vida brand of full spectrum sativa, indica and hybrid honey oil vapes in British Columbia, Alberta
Growing cannabis revenues, shrinking losses, a healthy balance sheet – and now a pathway to selling branded extraction products into the Canadian market.
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now.
By “nitty-gritty” we mean – numbers.
Four weeks ago, Heritage released its Q1, 2020 financials.
Heritage is now installing extraction and post-production equipment units at Empower’s existing licensed hemp processing facility in Sandy, Oregon, to begin performing “hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States”.
A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their yearly metrics filling the headlines, while their not-so-rough quarterly numbers were largely and inexplicably hidden from view.
Last week Empower Clinics (CBDT.C) announced that it has hired some young commissioned-based sales people to expand its Sollievo CBD line in Southern California. Empower
Two days ago, Zenabis Global (ZENA.T) formed an agreement with a Canadian beverage company, which will supply them the inputs required for Zenabis to enter
Endocanna Health, a subsidiary of Heritage Cannabis (CANN.C), has agreed to manufacture and license its patent-pending Endocannabinoid DNA Test Kits to Empower Clinics (CBDT.C). Imagine
Top tip: You guys out there whining about ‘the market’ being down are finding excuses for the wrong problem. Folks be running about with their
